Alan Tuck
Directeur/Bestuurslid bij Apogee Technology, Inc.
Profiel
Alan W.
Tuck is currently a Director at Apogee Technology, Inc. and a Director at Young Men's Christian Association of Greater Boston, Inc. Previously, he served as the President & Chief Executive Officer at T Cell Sciences, Inc. from 1992 to 1996.
He was also a Director at rEVO Biologics, Inc. from 1993 to 2010.
Additionally, he held the position of Chief Strategic Officer at ImmuLogic Pharmaceutical Corp.
from 1996 to 1998 and at Organogenesis, Inc. from 1997 to 2000.
He was the Chief Strategic Officer & Executive Vice President at Biocode, Inc. in 1998.
Furthermore, he worked as a Principal at The Bridgespan Group from 2011 to 2012.
Actieve functies van Alan Tuck
| Bedrijven | Functie | Begin |
|---|---|---|
Apogee Technology, Inc.
 Apogee Technology, Inc. Medical SpecialtiesHealth Technology Apogee Technology, Inc. is a biotechnology company which develops proprietary systems for the delivery of pharmaceutical agents into the skin for the treatment and prevention of local and systemic conditions. The company was founded in 1987 and is headquartered in Norwood, MA. | Directeur/Bestuurslid | 20-01-2010 |
Young Men's Christian Association of Greater Boston, Inc.
 Young Men's Christian Association of Greater Boston, Inc. Miscellaneous Commercial ServicesCommercial Services The YMCA of Greater Boston, Inc. provides social services. The firm offers youth development, healthy living and social responsibility services. It conducts pre-K, youth, teen, adult., family programs and provides early education care services. The company was founded in 1851 and is headquartered in Boston, MA. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Alan Tuck
| Bedrijven | Functie | Einde |
|---|---|---|
| REVO BIOLOGICS INC | Directeur/Bestuurslid | 06-12-2010 |
Organogenesis, Inc.
 Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Corporate Officer/Principal | 01-06-2000 |
Biocode, Inc.
 Biocode, Inc. Office Equipment/SuppliesProducer Manufacturing Biocode identifies counterfeit solid and liquid products using a covert method based on monoclonal antibody technology. And develops techniques to provide brand protection and identification to prevent counterfeitin | Corporate Officer/Principal | 01-06-1998 |
ImmuLogic Pharmaceutical Corp.
 ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | Corporate Officer/Principal | 01-06-1998 |
| T Cell Sciences, Inc. | President | 01-05-1996 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
ImmuLogic Pharmaceutical Corp.
ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | Health Technology |
Organogenesis, Inc.
Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Health Technology |
Apogee Technology, Inc.
Apogee Technology, Inc. Medical SpecialtiesHealth Technology Apogee Technology, Inc. is a biotechnology company which develops proprietary systems for the delivery of pharmaceutical agents into the skin for the treatment and prevention of local and systemic conditions. The company was founded in 1987 and is headquartered in Norwood, MA. | Health Technology |
| T Cell Sciences, Inc. | Health Technology |
Biocode, Inc.
Biocode, Inc. Office Equipment/SuppliesProducer Manufacturing Biocode identifies counterfeit solid and liquid products using a covert method based on monoclonal antibody technology. And develops techniques to provide brand protection and identification to prevent counterfeitin | Producer Manufacturing |
The Bridgespan Group
 The Bridgespan Group Miscellaneous Commercial ServicesCommercial Services The Bridgespan Group provides management strategies and tools. Its services include consulting to nonprofits and philanthropists, leadership development support, and developing and sharing insights. The company was founded by Thomas J. Tierney and Jeffrey L. Bradach and is headquartered in Boston, MA. | Commercial Services |
Young Men's Christian Association of Greater Boston, Inc.
Young Men's Christian Association of Greater Boston, Inc. Miscellaneous Commercial ServicesCommercial Services The YMCA of Greater Boston, Inc. provides social services. The firm offers youth development, healthy living and social responsibility services. It conducts pre-K, youth, teen, adult., family programs and provides early education care services. The company was founded in 1851 and is headquartered in Boston, MA. | Commercial Services |
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |
